Emerging Molecular Functions of MicroRNA-9: Cancer Pathology and Therapeutic Implications

(E-pub Ahead of Print)

Author(s): Behnam E.G. Tapeh, Bashir Mosayyebi, Behzad Mansoori, Zahra A. Gravand, Hamzeh Sarvnaz, Ali Mohammadi*

Journal Name: Anti-Cancer Agents in Medicinal Chemistry
(Formerly Current Medicinal Chemistry - Anti-Cancer Agents)


Become EABM
Become Reviewer
Call for Editor

Abstract:

MiRNAs that are characterized by small non-coding RNAs orchestrate the expression of important genes involved in cancer cell development processes including apoptosis, proliferation, angiogenesis, metastasis, and drug resistance at the post-transcriptional level. Dysregulation of miR-9 in various cancers has been reported. Recently, miR-9 has been considered as a key miRNA in various malignancies. However its importance in the pathogenesis of different neoplasms is not yet well defined. Accordingly, this study was conducted in order to clarify the potential roles of miR-9 in in the development of various cancers, prognosis, and treatment approaches. We have shown that a large number of miR-9 targets play fundamental roles in carcinogenesis and that is dysregulated in various cancer cells. Our findings was found aberrant miR-9 expression in a majority of cancers. This review article, generally emphasize on the critical roles of miR-9 in cancer cell progression. Additionally, we intended to investigate the effects of down-regulation or up-regulation of miR-9 in different types of cancers. It is hoped that a good understanding of the regulatory roles of miR-9 in various cancers be helpful for using miR-9 in the clinical settings including prognosis, diagnose, and miRNA based target therapy.

Keywords: Angiogenesis, cancer, drug resistance, miR-9, signaling pathway, proliferation

Rights & PermissionsPrintExport Cite as

Article Details

Published on: 16 February, 2021
(E-pub Ahead of Print)
DOI: 10.2174/1871520621666210217094839
Price: $95

Article Metrics

PDF: 143